PhaseBio Pharmaceuticals Buy Hold or Sell Recommendation
| PHASQDelisted Stock | USD 0.0003 0.0001 25.00% |
Assuming the 90 days horizon and your way above-average risk tolerance, our recommendation regarding PhaseBio Pharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell PhaseBio Pharmaceuticals given historical horizon and risk tolerance towards PhaseBio Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for PhaseBio Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Note, we conduct extensive research on individual companies such as PhaseBio and provide practical buy, sell, or hold advice based on investors' constraints. PhaseBio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
PhaseBio |
Execute PhaseBio Pharmaceuticals Buy or Sell Advice
The PhaseBio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on PhaseBio Pharmaceuticals. Macroaxis does not own or have any residual interests in PhaseBio Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PhaseBio Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
PhaseBio Pharmaceuticals Trading Alerts and Improvement Suggestions
| PhaseBio Pharmaceuticals is not yet fully synchronised with the market data | |
| PhaseBio Pharmaceuticals has some characteristics of a very speculative penny stock | |
| PhaseBio Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| PhaseBio Pharmaceuticals has accumulated 1.36 M in total debt. PhaseBio Pharmaceuticals has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PhaseBio Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, PhaseBio Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PhaseBio Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PhaseBio to invest in growth at high rates of return. When we think about PhaseBio Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 10.83 M. Net Loss for the year was (131.07 M) with loss before overhead, payroll, taxes, and interest of (91.28 M). | |
| PhaseBio Pharmaceuticals has accumulated about 7.8 M in cash with (47.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
PhaseBio Pharmaceuticals Returns Distribution Density
The distribution of PhaseBio Pharmaceuticals' historical returns is an attempt to chart the uncertainty of PhaseBio Pharmaceuticals' future price movements. The chart of the probability distribution of PhaseBio Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use PhaseBio Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PhaseBio Pharmaceuticals returns is essential to provide solid investment advice for PhaseBio Pharmaceuticals.
| Mean Return | 200.58 | Value At Risk | -66.67 | Potential Upside | 200.00 | Standard Deviation | 50.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PhaseBio Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PhaseBio Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PhaseBio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.25 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.75 | |||
| Day Median Price | 4.0E-4 | |||
| Day Typical Price | 3.0E-4 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0001) |
About PhaseBio Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell PhaseBio Pharmaceuticals? Buying financial instruments such as PhaseBio Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PhaseBio Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in PhaseBio Pink Sheet
If you are still planning to invest in PhaseBio Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseBio Pharmaceuticals' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |